Epigenetic targeting for acute kidney injury

Area of Science:

• Nephrology
• Molecular Biology
• Epigenetics

Background:

• Epigenetic modifications are increasingly recognized as critical regulators in disease pathogenesis, including acute kidney injury (AKI).
• AKI is associated with alterations in histone modifications, DNA methylation, and non-coding RNA expression.
• The precise roles of these epigenetic changes in AKI are under active investigation.

Purpose of the Study:

• To discuss the role and mechanisms of histone acetylation and methylation in the pathogenesis of AKI.
• To review the current understanding of how epigenetic modifications influence kidney injury.
• To highlight the therapeutic potential of targeting epigenetic pathways in AKI.

Main Methods:

• Review of existing literature on epigenetics in AKI.
• Analysis of studies utilizing histone deacetylase (HDAC) inhibitors.
• Examination of research on histone methyltransferase inhibition in AKI models.

Main Results:

• Histone acetylation modulation via HDAC inhibitors can either protect against or exacerbate kidney injury, depending on the specific HDAC targeted.
• Inhibition of histone methyltransferase generally demonstrates a protective effect in AKI.
• The role of DNA methylation in AKI pathogenesis remains largely unclear.

Conclusions:

• Histone acetylation and methylation are significant epigenetic mechanisms involved in AKI.
• Targeting specific histone modifications offers potential therapeutic strategies for AKI.
• Further research is needed to elucidate the role of DNA methylation in AKI.